Last reviewed · How we verify
Topical treatment
Topical treatment is a Small molecule drug developed by Aresus Pharma GmbH. It is currently FDA-approved. Also known as: Veregen 10% ointment.
Topical treatments have been studied for various skin conditions, including atopic dermatitis and skin carcinoma, as well as for improving skin smoothness, radiance, and overall appearance. The treatments used in these studies include a biocellulose mask, post-procedure cream, and gentle cleanser, but the exact mechanism of action is currently unknown.
At a glance
| Generic name | Topical treatment |
|---|---|
| Also known as | Veregen 10% ointment |
| Sponsor | Aresus Pharma GmbH |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- A Phase 2, Baseline-Controlled Study Evaluating the Safety and Efficacy of PTX-022 (Sirolimus) Topical Gel 3.9% in the Treatment of Cutaneous Venous Malformations (PHASE2)
- Topical Methylene Blue-Photodynamic Therapy (MB-PDT) for Burn Wound Infection (PHASE1, PHASE2)
- Analgesic Efficacy and Safety of Topical VMD-3866 Gel in Management of Pain Induced by Chemotherapy (CIPN) (PHASE2)
- Loteprednol Etabonate Versus Prednisolone Acetate for Anterior Chamber Granulomas (PHASE4)
- Durability of Three Monthly Loading Doses With Faricimab in Treatment-naïve Neovascular Age-related Macular Degeneration
- SELVA: A Phase 3 Study Evaluating QTORIN 3.9% Rapamycin Anhydrous Gel in the Treatment of Microcystic Lymphatic Malformations (PHASE3)
- Comparison of 4 Methods of Eye Drops for Pupil Dilation in Diabetic Patients (NA)
- A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Topical treatment CI brief — competitive landscape report
- Topical treatment updates RSS · CI watch RSS
- Aresus Pharma GmbH portfolio CI
Frequently asked questions about Topical treatment
What is Topical treatment?
Who makes Topical treatment?
Is Topical treatment also known as anything else?
What development phase is Topical treatment in?
Related
- Manufacturer: Aresus Pharma GmbH — full pipeline
- Also known as: Veregen 10% ointment
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing